论文部分内容阅读
阿地溴铵(aclidinium bromide)是西班牙Almirall制药公司和美国Forest实验室共同研发的一种抗毒蕈碱类药物。该药于2012年7月获美国FDA批准上市,商品名为Tudorza Pressair,剂型为粉末吸入剂。阿地溴铵用于慢性阻塞性肺病(COPD)引起的支气管痉挛的长期维持治疗,包括慢性支气管炎和肺气肿等。
Aclidinium bromide is an anti-muscarinic drug jointly developed by Almirall Pharmaceuticals in Spain and Forest Laboratories in the United States. The drug was approved by the US FDA in July 2012 and is marketed under the trade name Tudorza Pressair in the form of a powder inhaler. Abidium bromide for chronic obstructive pulmonary disease (COPD) caused by bronchospasm long-term maintenance treatment, including chronic bronchitis and emphysema.